About Careers Internship MedBlog Contact us

Three More MERS Deaths in Saudi Arabia

by Himabindu Venkatakrishnan on May 12, 2014 at 10:14 AM
 Three More MERS Deaths in Saudi Arabia

Report of three new deaths from MERS coronavirus in Saudi Arabia takes the number of fatalities from the disease in the kingdom to 142, said health ministry on Sunday.

The Middle East Respiratory System coronavirus has now infected 483 people in the Gulf nation since it first appeared in 2012, accounting for the vast majority of the 496 cases registered worldwide.


In its daily bulletin, the ministry said a 45-year-old man had died from MERS in Jeddah on the west coast, and two women aged 60 and 62 died in the capital, Riyadh.

The announcement came as the World Health Organisation prepared for an emergency meeting to discuss the disease on Tuesday.

The UN health agency's emergency committee has already met four times to discuss the mysterious coronavirus.

MERS is considered a deadlier but less-transmissible cousin of the SARS virus that broke out in Asia in 2003, infecting 8,273 people and killing nearly 800.

Like SARS, it appears to cause a lung infection, with patients suffering coughing, breathing difficulties and a temperature, but MERS differs in that it also causes rapid kidney failure.

Although most MERS infections have been in Saudi Arabia, cases have also been recorded in the United Arab Emirates, Jordan, Egypt, Lebanon and even the United States.

Most cases outside Saudi Arabia involve people who had traveled to the kingdom or worked there, often as medical staff.

Source: AFP
Font : A-A+



Recommended Readings

Latest Coronavirus News

Free At-Home COVID-19 Test Kits Return to US on September 25th
Free at-home coronavirus tests were initially distributed to Americans via the Postal Service in early 2022, in response to the surge in Omicron cases.
Tau Proteins: Key Players in Understanding COVID-19 Brain Fog
In Alzheimer's disease patients, COVID-19 infection may exacerbate cognitive symptoms, including brain fog.
Early Convalescent Plasma Use May Reduce Severe COVID and Long COVID Risk
COVID-19 patients receiving early convalescent plasma treatment are less likely to develop post-COVID (long COVID) with SARS-CoV-2 antibodies.
The Return of Masks and Lockdowns
Discussions gain traction on the resurgence of masks and limited lockdowns this winter amid rising COVID variants.
Meeting the Challenge of Evolving COVID Strains
India stands prepared to develop vaccines for any new COVID strain, as stated by Indian Council of Medical Research (ICMR).
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Three More MERS Deaths in Saudi Arabia Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests